Evaluation of Preventive Effect of tofogliflozin on cardiovascular function in type 2 diabetes with cardiovascular diseases
Not Applicable
- Conditions
- type 2 diabetes with cardiovascular disease
- Registration Number
- JPRN-UMIN000018344
- Lead Sponsor
- tofogliflozin study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) BMI < 18.0 2) history of cerebral infarction 3) patients whose dose of diuretics are changed within 3 months 4) estimated GFR < 45 ml/min 5) patients inplanted pacemaker 6) patients with pregnancy and lactation 7) patiets enrolled other clinical trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method BNP, marker of cardiac echography after 6 months
- Secondary Outcome Measures
Name Time Method